Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs.

Audrey MailletElise MétéreauLéon TremblayEmilie FavreHélène KlingerEugénie LhomméeDidier Le BarsAnna CastriotoStéphane Prange Véronique SgambatoEmmanuel BroussollePaul KrackStéphane Thobois

Published in: Movement disorders : official journal of the Movement Disorder Society (2021)

Altogether, these findings highlight the prominent role of serotonergic degeneration in the expression of several neuropsychiatric symptoms occurring after different durations of Parkinson's disease. © 2021 International Parkinson and Movement Disorder Society.

Keyphrases

poor prognosis
binding protein
sleep quality
long non coding rna